Aptevo Therapeutics annual operating margin
2015
2016
2017
2018
2019
2020
2021
2022
Aptevo Therapeutics Operating Margin Growth & History (APVO)
Aptevo Therapeutics's operating margin was −919.75% for fiscal 2022.
View full Aptevo Therapeutics company overviewAptevo Therapeutics annual operating margin history
| Fiscal year | Period ended | Operating margin | Change (percentage points) |
|---|---|---|---|
| 2022 | 2022-12-31 | −919.75% | −745.65 pp |
| 2021 | 2021-12-31 | −174.10% | +463.96 pp |
| 2020 | 2020-12-31 | −638.06% | −511.73 pp |
| 2019 | 2019-12-31 | −126.33% | +97.65 pp |
| 2018 | 2018-12-31 | −223.98% | +144.07 pp |
| 2017 | 2017-12-31 | −368.05% | +1021.76 pp |
| 2016 | 2016-12-31 | −1,389.81% | −1207.97 pp |
| 2015 | 2015-12-31 | −181.84% | — |
Aptevo Therapeutics quarterly operating margin
Q2.15
Q3.15
Q1.16
Q2.16
Q3.16
Q1.17
Q2.17
Q3.17
Q4.17
Q1.18
Q2.18
Q3.18
Q4.18
Q1.19
Q2.19
Q3.19
Q4.19
Q2.20
Q3.20
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
| Fiscal quarter | Period ended | Operating margin | Change (percentage points) |
|---|---|---|---|
| Q1 2022 | 2022-03-31 | −180.19% | +104.32 pp |
| Q4 2021 | 2021-12-31 | −110.23% | +316.70 pp |
| Q3 2021 | 2021-09-30 | −153.42% | +1285.69 pp |
| Q2 2021 | 2021-06-30 | −183.99% | −126.77 pp |
| Q1 2021 | 2021-03-31 | −284.51% | −157.34 pp |
| Q3 2020 | 2020-09-30 | −426.93% | −251.71 pp |
| Q2 2020 | 2020-06-30 | −1,439.11% | −1276.20 pp |
| Q4 2019 | 2019-12-31 | −57.21% | +156.98 pp |
| Q3 2019 | 2019-09-30 | −127.17% | +81.06 pp |
| Q2 2019 | 2019-06-30 | −175.22% | +7.09 pp |
| Q1 2019 | 2019-03-31 | −162.92% | +168.72 pp |
| Q4 2018 | 2018-12-31 | −214.20% | +382.71 pp |
| Q3 2018 | 2018-09-30 | −208.22% | −40.56 pp |
| Q2 2018 | 2018-06-30 | −182.30% | +233.15 pp |
| Q1 2018 | 2018-03-31 | −331.64% | +234.70 pp |
| Q4 2017 | 2017-12-31 | −596.91% | +2617.75 pp |
| Q3 2017 | 2017-09-30 | −167.66% | −41.64 pp |
| Q2 2017 | 2017-06-30 | −415.46% | −254.54 pp |
| Q1 2017 | 2017-03-31 | −566.34% | −365.36 pp |
| Q3 2016 | 2016-09-30 | −3,214.67% | −2956.42 pp |
| Q2 2016 | 2016-06-30 | −126.02% | — |
| Q1 2016 | 2016-03-31 | −160.91% | — |
| Q3 2015 | 2015-09-30 | −200.98% | — |
| Q2 2015 | 2015-06-30 | −258.25% | — |
Aptevo Therapeutics operating margin trends
Over the last five reported fiscal years, Aptevo Therapeutics's operating margin decreased from −368.05% to −919.75%, a change of −551.70 percentage points. The latest reported quarter, Q1 2022, shows −180.19%.
About the metric
What operating margin means
Operating margin measures the percentage of revenue left after operating costs and expenses. It shows how much operating profit a company generates from each dollar of revenue.
Calculation and source
How operating margin is calculated
TickerStat calculates operating margin as SEC-reported operating income divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Aptevo Therapeutics filings at SEC.gov ↗